ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma

被引:0
|
作者
Qian Chen
Xiao-Wei Zhou
Ai-Jun Zhang
Kang He
机构
[1] Shanghai Jiaotong University,Reproductive Medical Center, Department of Obstetrics and Gynecology of Ruijin Hospital, School of Medicine
[2] Shanghai Jiaotong University,Department of Liver Surgery, Renji Hospital, School of Medicine
关键词
ACTN1; Poor prognosis; Tumor growth; Hepatocellular carcinoma; Hippo signaling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma (vol 40, 23, 2021)
    Chen, Qian
    Zhou, Xiao-Wei
    Zhang, Ai-Jun
    He, Kang
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [2] High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma
    Xie, Guo-feng
    Zhao, Luo-dan
    Chen, Qiang
    Tang, Dong-xiao
    Chen, Qiong-yu
    Lu, Hong-fei
    Cai, Jia-rong
    Chen, Zheng
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1717 - 1727
  • [3] PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma
    Huang, Zhao
    Zhou, Jian-Kang
    Wang, Kui
    Chen, Haining
    Qin, Siyuan
    Liu, Jiayang
    Luo, Maochao
    Chen, Yan
    Jiang, Jingwen
    Zhou, Li
    Zhu, Lei
    He, Juan
    Li, Jiao
    Pu, Wenchen
    Gong, Yanqiu
    Li, Jianbo
    Ye, Qin
    Dong, Dandan
    Hu, Hongbo
    Zhou, Zongguang
    Dai, Lunzhi
    Huang, Canhua
    Wei, Xiawei
    Peng, Yong
    [J]. HEPATOLOGY, 2020, 71 (05) : 1643 - 1659
  • [4] ACTN1 promotes malignant progression in cutaneous squamous cell carcinoma by downregulating the p53 signaling pathway
    Yuan Tao
    Lu Xiaohong
    Jiang Jiahui
    Chen Nan
    Tang Biao
    He Caifeng
    Liu Wenbei
    Wang Jun
    Ci Chao
    [J]. 中华医学杂志英文版., 2024, 137 (14)
  • [5] The value of ACTN1 in the diagnosis of cutaneous squamous cell carcinoma: A continuation study
    Tao, Yuan
    Xiao-hong, Lu
    Guo-lin, Ke
    Hua, Hu
    Jia-hui, Jiang
    Chao, Ci
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (04)
  • [6] PCK1 attenuates tumor stemness via activating the Hippo signaling pathway in hepatocellular carcinoma
    Liu, Rui
    Liu, Yi
    Zhang, Wenlu
    Zhang, Guiji
    Zhang, Zhirong
    Huang, Luyi
    Tang, Ni
    Wang, Kai
    [J]. GENES & DISEASES, 2024, 11 (04)
  • [7] STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway
    Zhu, Jie
    Tang, Wenjia
    Fang, Peiqi
    Wang, Chong
    Gu, Meixiu
    Yang, Wenjing
    Pan, Baishen
    Wang, Beili
    Guo, Wei
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (06)
  • [8] ACTN1 promotes malignant progression in cutaneous squamous cell carcinoma by downregulating the p53 signaling pathway
    Yuan, Tao
    Lu, Xiaohong
    Jiang, Jiahui
    Chen, Nan
    Tang, Biao
    He, Caifeng
    Liu, Wenbei
    Wang, Jun
    Ci, Chao
    [J]. CHINESE MEDICAL JOURNAL, 2024, 137 (14) : 1759 - 1761
  • [9] Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
    Liu, Yuchen
    Wang, Xiaohui
    Yang, Yingzi
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 742 - 750
  • [10] Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling
    Zhang, Xiaodong
    Fan, Qing
    Li, Yan
    Yang, Zhaoguo
    Yang, Liang
    Zong, Zhihong
    Wang, Biao
    Meng, Xin
    Li, Qin
    Liu, Jingang
    Li, Hangyu
    [J]. ONCOTARGET, 2017, 8 (18) : 29785 - 29794